Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pierre Esseiva is a Swiss forensic science consultancy and individual enterprise led by Professor Pierre Esseiva, a renowned expert in forensic chemistry and drug profiling. The firm provides specialized technical expertise to law enforcement agencies, judicial bodies, and international organizations regarding the analysis of illicit drug markets and narcotics characterization. Its core activities involve the chemical profiling of substances such as cocaine, heroin, and synthetic drugs to identify trafficking patterns and support criminal intelligence. Additionally, the entity offers consulting services for the development of analytical methods and the interpretation of toxicological data. By bridging academic research from the University of Lausanne with practical forensic applications, Pierre Esseiva plays a critical role in the scientific fight against drug-related crime and the monitoring of public health threats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pierre Esseiva.